Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLXNC1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0005 |
mRNA | GOLGA8R | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | HLA-DQA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | ICAM4 | FIMM | pan-cancer | AAC | 0.69 | 0.0005 |
mRNA | DEF6 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0005 |
mRNA | NUP43 | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
mRNA | ITK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | IGF2R | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ARHGEF6 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0005 |
mRNA | BCAS4 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |